Latest Innovations
The Latest Life Science Innovations Changing Patients Lives
Click the social share buttons below to keep your network up to date on the latest life science innovations changing patients lives.
Sign Up - Newsletter
Sign up for our regular newsletter to receive the latest trends and news from the California Biotechnology Industry
The Latest on Life Science Innovations
The California Biotechnology Foundation is committed to keeping you up to date about the latest breakthroughs in biotech treatments and the impact of one of California’s largest industries in the state and beyond. This newsletter edition, as of September 24, 2025, brings you updates directly from the forefront of medical innovation. Among the notable advancements featured are:
-
Amgen and Gilead are making major investments in California—nearly $1.5 billion combined—to expand research, development and manufacturing operations, creating thousands of jobs and bolstering the state’s leadership in life sciences.
-
Johnson & Johnson’s INLEXZO won FDA approval as the first new bladder cancer therapy in 40 years, providing a bladder-sparing option for BCG-unresponsive patients.
-
GLP-1 drugs like Ozempic are showing promise beyond weight loss and diabetes—early research suggests they may lower cancer risk, improve immune responses, and enhance the effects of chemotherapy and immunotherapy by influencing multiple biological pathways.